Literature DB >> 27276856

Clinical trial/experimental study (consort compliant): Optimal time period to achieve the effects on synbiotic-controlled wheezing and respiratory infections in young children.

Andjelka Stojković, Aleksandra Simović, Zoran Bogdanović, Dragić Banković, Mina Poskurica.   

Abstract

INTRODUCTION: Urban life is often followed by immune dysfunction and loss of immune tolerance in the youngest children.
OBJECTIVE: The study aimed to determine optimal time efficiency of a synbiotic (5 x 10⁹ Lactobacillus acidophilus Rosell-52, Bifidobacterium infantis Rosell-33, Bifidobacterium bifidum Rosell-71) in controlling respiratory infections and wheezing disease.
METHODS: We randomly selected a group of children younger than five years, hospitalized earlier, and classified them into three groups.
RESULTS: The incidence of respiratory infection before the study was once a month, while after a three-month supplementation with the synbiotic children rarely suffered from respiratory infections, and the state was maintained after six-month and nine-month supplementations with the synbiotic. The decreased incidence of respiratory infections was followed by a falling incidence of concomitant wheezing. A significant increase in tIgA serum was observed in all groups for only three months, the increase being the highest in children with recurrent respiratory infections accompanied by wheezing. After a nine-month administration of the synbiotic, total IgE serum was lower in all groups of patients.
CONCLUSION: The optimal duration of administration of the synbiotic containing three probiotic cultures to provide effective control of the frequency of respiratory infections was three months, and six months were required to establish control of the frequency of wheezing. This synbiotic is useful for immunomodulation in children and is well-tolerated in young children.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27276856     DOI: 10.2298/sarh1602038s

Source DB:  PubMed          Journal:  Srp Arh Celok Lek        ISSN: 0370-8179            Impact factor:   0.207


  4 in total

Review 1.  Probiotics for preventing acute upper respiratory tract infections.

Authors:  Yunli Zhao; Bi Rong Dong; Qiukui Hao
Journal:  Cochrane Database Syst Rev       Date:  2022-08-24

2.  Methodological Errors in Clinical Studies Published by Medical Journals of Ex-Yugoslav Countries.

Authors:  Slobodan M Jankovic; Izet Masic
Journal:  Acta Inform Med       Date:  2020-06

3.  Probiotics for preventing acute otitis media in children.

Authors:  Anna M Scott; Justin Clark; Blair Julien; Farhana Islam; Kristian Roos; Keith Grimwood; Paul Little; Chris B Del Mar
Journal:  Cochrane Database Syst Rev       Date:  2019-06-18

Review 4.  Efficacy of a Multi-Strain Probiotic Formulation in Pediatric Populations: A Comprehensive Review of Clinical Studies.

Authors:  Annie Tremblay; Xiaoyu Xu; James Colee; Thomas A Tompkins
Journal:  Nutrients       Date:  2021-06-01       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.